SCHEMBL7649684

SCHEMBL7649684

CCOC(=O)C(C)(C)n1c(=O)[nH]c2ccc(Cl)cc2c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.51
CA9 Q16790 1/20 0.51
CSF1R P07333 1/20 0.46
ALDH1A1 P00352 4/20 0.46
HPGD P15428 3/20 0.46
CYP1A2 P05177 3/20 0.46
CYP2C19 P33261 2/20 0.46
XBP1 P17861 1/20 0.46
SIRT1 Q96EB6 4/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
LMNA P02545 3/20 0.43
MAPT P10636 2/20 0.43
TSHR P16473 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HSD17B10 Q99714 1/20 0.42
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7648344 0.91 CA9 (0.51) CA12CA9HPGDHSD17B10
SCHEMBL7649595 0.88 KDM4E (0.47) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL7651932 0.86 FEN1 (0.51) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL7651842 0.86 CA12 (0.51) CA12CA9CSF1RALDH1A1HPGD
SCHEMBL7652031 0.84 CA12 (0.44) CA12CA9CSF1RALDH1A1HPGD
SCHEMBL7652236 0.83 SMN1; SMN2 (0.55) CA12CA9ALDH1A1HPGDCYP1A2
SCHEMBL7655193 0.82 CA12 (0.58) CA12CA9CSF1RALDH1A1HPGD
SCHEMBL7657940 0.82 CA12 (0.55) CA12CA9ALDH1A1MEN1KMT2A
SCHEMBL7651738 0.82 SMN1; SMN2 (0.43) CA12CA9CSF1RALDH1A1HPGD
SCHEMBL7653151 0.81 KDM4E (0.44) ALDH1A1HPGDMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407116-B1 2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLINE DERIVATIVES; ANTIALLERGENS, ANTIASTHMATICS, ANTIHISTAMINES, AND ANTIINFLAMMATORY AGENTS TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2002-06-18 US disclosed
EP-1026160-A1 NITROGENOUS FUSED-RING COMPOUNDS, PROCESS FOR THE PREPARATION OF THE SAME, AND DRUGS Takeda Chemical Industries, Ltd. (JP) 2000-08-09 EP disclosed